2017
Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [18F]Fluoromisonidazole ([18F]FMISO) Kinetic Analysis and Invasive Oxygen Measurements
Kelada OJ, Rockwell S, Zheng MQ, Huang Y, Liu Y, Booth CJ, Decker RH, Oelfke U, Carson RE, Carlson DJ. Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [18F]Fluoromisonidazole ([18F]FMISO) Kinetic Analysis and Invasive Oxygen Measurements. Molecular Imaging And Biology 2017, 19: 893-902. PMID: 28409339, PMCID: PMC5640490, DOI: 10.1007/s11307-017-1083-9.Peer-Reviewed Original ResearchConceptsPositron emission tomographyTumor hypoxic fractionHypoxic fractionEmission tomographyLung cancer radiotherapy patientsPO2 measurementsAbsolute tumor volumeC miceDirect pO2 measurementsBlood ratioClinical impactTumor volumeHypoxia quantificationSubcutaneous tumorsPurposeThe purposeTracer kinetic modelingRadiotherapy patientsPET imagingPatientsPO2 valuesScansPatlak modelTomographyTwo-compartmentTBR
2013
MO‐D‐141‐01: Quantification of Tumor Hypoxia Using [18F]‐Fluoromisonidazole Positron Emission Tomography and Tracer Kinetic Modeling
Kelada O, Rockwell S, Carson R, Decker R, Oelfke U, Carlson D. MO‐D‐141‐01: Quantification of Tumor Hypoxia Using [18F]‐Fluoromisonidazole Positron Emission Tomography and Tracer Kinetic Modeling. Medical Physics 2013, 40: 399-399. DOI: 10.1118/1.4815248.Peer-Reviewed Original ResearchPositron emission tomographyBlood ratioComputed tomographyFluoromisonidazole positron emission tomographyMale BALB/c miceEmission tomographyTumor hypoxiaBALB/c miceEMT-6 tumorsNon-invasive imaging methodVoxel basisTreatment failureC miceConventional tumorHypoxia quantificationHypoxic fractionAnaesthetized animalsTumorsHistologic sectionsPharmacokinetic modelPharmacokinetic modelingDynamic positron emission tomographyPET imagingHypoxic radioresistanceBetter delineation